SNYNF (Sanofi) Ending Cash Position : $676 Mil (As of Dec. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Sanofi Ending Cash Position?

Sanofi's Ending Cash Position for the quarter that ended in Dec. 2024 was $676 Mil.

Sanofi's quarterly Ending Cash Position increased from Dec. 2023 ($782 Mil) to Jun. 2024 ($7,314 Mil) but then declined from Jun. 2024 ($7,314 Mil) to Dec. 2024 ($676 Mil).

Sanofi's annual Ending Cash Position declined from Dec. 2022 ($13,492 Mil) to Dec. 2023 ($9,498 Mil) and declined from Dec. 2023 ($9,498 Mil) to Dec. 2024 ($7,792 Mil).

Sanofi Ending Cash Position Historical Data

The historical data trend for Sanofi's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sanofi Ending Cash Position Chart

Sanofi Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

16,928.22

11,410.17

13,491.53

9,498.36

7,791.62

Sanofi Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Ending Cash Position	Get a 7-Day Free Trial															6,183.26	8,659.81	781.90	7,314.32	676.44

Sanofi Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Sanofi's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	8945.55	+	-1153.927
	=	7,792

Sanofi's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	-174.868	+	851.308
	=	676

Sanofi Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Sanofi's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Sanofi Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanofi SA (OTCPK:SNYNF) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

SNY:USA SNY N:Mexico 1SAN:Italy 0A2V:UK SANp:UK 0O59:UK SAN:France SNW:Germany SNW2:Germany SNW:Germany SNW:Germany SNW2:Germany SNW:Germany SNW:Bulgaria SANO:Austria

Address

46, Avenue de la Great Army, Paris, FRA, 75017

Website

https://www.sanofi.com

Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.